234 related articles for article (PubMed ID: 27309887)
1. Subretinal Fluid Associated With MEK Inhibitor Use in the Treatment of Systemic Cancer.
Weber ML; Liang MC; Flaherty KT; Heier JS
JAMA Ophthalmol; 2016 Aug; 134(8):855-62. PubMed ID: 27309887
[TBL] [Abstract][Full Text] [Related]
2. Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.
van Dijk EH; van Herpen CM; Marinkovic M; Haanen JB; Amundson D; Luyten GP; Jager MJ; Kapiteijn EH; Keunen JE; Adamus G; Boon CJ
Ophthalmology; 2015 Sep; 122(9):1907-16. PubMed ID: 26123090
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.
Francis JH; Habib LA; Abramson DH; Yannuzzi LA; Heinemann M; Gounder MM; Grisham RN; Postow MA; Shoushtari AN; Chi P; Segal NH; Yaeger R; Ho AL; Chapman PB; Catalanotti F
Ophthalmology; 2017 Dec; 124(12):1788-1798. PubMed ID: 28709702
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy.
Francis JH; Canestraro J; Haggag-Lindgren D; Harding JJ; Diamond EL; Drilon A; Li BT; Iyer G; Schram AM; Abramson DH
Ophthalmol Retina; 2021 Dec; 5(12):1187-1195. PubMed ID: 34102344
[TBL] [Abstract][Full Text] [Related]
6. Pimasertib-associated ophthalmological adverse events.
van Dijk EHC; Kruit WHJ; Jager MJ; Luyten GPM; Vingerling JR; Boon CJF
Acta Ophthalmol; 2018 Nov; 96(7):712-718. PubMed ID: 29338133
[TBL] [Abstract][Full Text] [Related]
7. Long-term results and recurrence rates after spironolactone treatment in non-resolving central serous chorio-retinopathy (CSCR).
Herold TR; Rist K; Priglinger SG; Ulbig MW; Wolf A
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):221-229. PubMed ID: 27475933
[TBL] [Abstract][Full Text] [Related]
8. Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration.
Waldstein SM; Philip AM; Leitner R; Simader C; Langs G; Gerendas BS; Schmidt-Erfurth U
JAMA Ophthalmol; 2016 Feb; 134(2):182-90. PubMed ID: 26661463
[TBL] [Abstract][Full Text] [Related]
9. Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy.
Shulman S; Goldenberg D; Schwartz R; Habot-Wilner Z; Barak A; Ehrlich N; Loewenstein A; Goldstein M
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):15-22. PubMed ID: 25794988
[TBL] [Abstract][Full Text] [Related]
10. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
Lee H; Lee J; Chung H; Kim HC
Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
[TBL] [Abstract][Full Text] [Related]
11. Correlation between outer retinal layer thickness and cone density in patients with resolved central serous chorioretinopathy.
Nakamura T; Ueda-Consolvo T; Oiwake T; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2347-2354. PubMed ID: 27255458
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy.
Ahn SE; Oh J; Oh JH; Oh IK; Kim SW; Huh K
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5944-52. PubMed ID: 23920371
[TBL] [Abstract][Full Text] [Related]
13. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study.
Pitcher JD; Witkin AJ; DeCroos FC; Ho AC
Br J Ophthalmol; 2015 Jun; 99(6):848-52. PubMed ID: 25595177
[TBL] [Abstract][Full Text] [Related]
14. MEK inhibitor-associated retinopathy (MEKAR) in metastatic melanoma: Long-term ophthalmic effects.
Urner-Bloch U; Urner M; Jaberg-Bentele N; Frauchiger AL; Dummer R; Goldinger SM
Eur J Cancer; 2016 Sep; 65():130-8. PubMed ID: 27497344
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
[TBL] [Abstract][Full Text] [Related]
16. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
Nazari H; Rao NA
Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
[TBL] [Abstract][Full Text] [Related]
17. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
[TBL] [Abstract][Full Text] [Related]
18. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy.
Gerendas BS; Kroisamer JS; Buehl W; Rezar-Dreindl SM; Eibenberger KM; Pablik E; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2018 Nov; 96(7):e776-e782. PubMed ID: 29338130
[TBL] [Abstract][Full Text] [Related]
19. A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial.
Zhao M; Zhang F; Chen Y; Dai H; Qu J; Dong C; Kang X; Liu Y; Yang L; Li Y; Zhou P; Pan CT; Zhang L; Liu P; Zhou H; Jiao X; Xiong Y; Tian R; Lu Y; Yu X; Li X
JAMA Ophthalmol; 2015 Mar; 133(3):333-40. PubMed ID: 25555191
[TBL] [Abstract][Full Text] [Related]
20. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
Bae SH; Heo J; Kim C; Kim TW; Shin JY; Lee JY; Song SJ; Park TK; Moon SW; Chung H
Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
